• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intracranial Hemorrhage (1891); Ischemia (1942)
Event Type  malfunction  
Manufacturer Narrative
The device was not returned for analysis as they were implanted in the patients.Attempts have been made to obtain additional information, however, our attempts were unsuccessful.The flow diverter device performed as intended; as indicated by successful deployment of the device in the intended landing zone to treat an aneurysm located.There was no device issue reported during the procedure.Intracranial hemorrhage and ischemia are known inherent risk of endovascular procedure and is documented in the flow diverter device¿s instruction for use (ifu).In these events, the cause of the intracranial hemorrhage and the ischemic event cannot be reliably determined; however, per the reported information, and review of ifu, the most likely cause for the complaint is the patients¿ condition.Linked events: 2029214-2017-00666 2029214-2017-00667.
 
Event Description
Citation: ¿flow diversion in ruptured intracranial aneurysms: a meta-analysis¿ t.P.Madaelil, c.J.Moran, d.T.Cross and a.P.Kansagra american journal of neuroradiology march 2017, 38 (3) 590-595; doi: https://doi.Org/10.3174/ajnr.A5030 medtronic received report that the flow diverter (fd) was used to treatment121of 126 patients, competitive flow diverter was used in the remaining 5/126 of cases.Aneurysm re-rupture occurred following fd placement in 6/126 of aneurysms.4 re-ruptures occurred during or within the first 24 hours of treatment.Hemorrhagic complications not related to aneurysm re-rupture occurred in 5/126 of patients.One was an asymptomatic cerebellar hemorrhage.Ischemic complications occurred in 5/111 of patients, of whom 4/111 were symptomatic.Median age was 51 years (interquartile range, 45¿60 years), and 71% of patients were women.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9492753836
MDR Report Key6580351
MDR Text Key75615953
Report Number2029214-2017-00667
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 04/24/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/24/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-